A new gene therapy for the fatal genetic disorder metachromatic leukodystrophy, or MLD, will carry a wholesale price of $4.25 million, its manufacturer announced Wednesday, making it the world’s most expensive medicine. Lenmeldy was approved by the US Food and Drug Administration on Monday and is…
#mld #lenmeldy #medicaid #bobbygaspar #orchardtherapeutics #kendrariley #phoenix #fda #riley #olivia
Continue reading...